We are live on ! Find out more
CLB icon

Core Laboratories

181 hedge funds and large institutions have $1.14B invested in Core Laboratories in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 78 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $4.21M | Put options by funds: $2.07M

81% more capital invested

Capital invested by funds: $630M → $1.14B (+$513M)

2.76% more ownership

Funds ownership: 94.08%96.84% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 187181 (-6)

14% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 28

37% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 78

Holders
181
Holders Change
-6
Holders Change %
-3.21%
% of All Funds
3.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
49
Reduced
78
Closed
28
Calls
$4.21M
Puts
$2.07M
Net Calls
+$2.14M
Net Calls Change
+$782K

CLB Hedge Fund Activity: Q4 2020 in Review

181 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2020, worth a combined $1.14B — up 81% from $630M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CLB and 24 opened new positions — a net loss of 4 holders — while 78 trimmed existing stakes and 49 added.

The largest buyer was Ariel Investments, adding an estimated $27.4M. The largest seller was Truist Financial, cutting an estimated $9.44M.

  • 181 institutional investors held Core Laboratories (CLB) as of Q4 2020, down from 187 in Q3 2020.
  • Funds reported $1.14B of Core Laboratories stock for Q4 2020, up 81% quarter-over-quarter.
  • 24 funds opened new Core Laboratories positions in Q4 2020 and 28 closed out, a net change of -4 holders.
  • The largest Core Laboratories buyer in Q4 2020 was Ariel Investments, an estimated $27.4M added.
  • The largest Core Laboratories seller in Q4 2020 was Truist Financial, an estimated $9.44M sold.

Based on aggregated 13F filings for Q4 2020.